This Article Full Text Full Text (PDF) All Versions of this Article: 112/14/2169    most recent CIRCULATIONAHA.104.530428v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dilsizian, V. Articles by Udelson, J. E. Search for Related Content PubMed PubMed Citation Articles by Dilsizian, V. Articles by Udelson, J. E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Biochemistry and metabolism Cardiovascular imaging agents/Techniques Imaging Nuclear cardiology and PET Chronic ischemic heart disease

(Circulation. 2005;112:2169-2174.)
© 2005 American Heart Association, Inc.

Imaging

Metabolic Imaging With ß-Methyl-p-[¹²³I]-Iodophenyl-Pentadecanoic Acid Identifies Ischemic Memory After Demand Ischemia

Vasken Dilsizian, MD; Timothy M. Bateman, MD; Steven R. Bergmann, MD, PhD; Roger Des Prez, MD; Martin Y. Magram, MD; Anne E. Goodbody, PhD; John W. Babich, PhD; James E. Udelson, MD

From the Division of Nuclear Medicine, University of Maryland Hospital and School of Medicine, Baltimore (V.D., M.Y.M.); Cardiovascular Consultants, Kansas City, Mo (T.M.B.); Cardiovascular Division, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY (S.R.B.); Oklahoma Heart Institute, Tulsa (R.D.P.); Molecular Insight Pharmaceuticals, Inc, Cambridge, Mass (A.E.G., J.W.B.); and Division of Cardiology, Tufts-New England Medical Center and Tufts University School of Medicine, Boston, Mass (J.E.U.).

Correspondence to Vasken Dilsizian, MD, University of Maryland Hospital and School of Medicine, 22 S Greene St, Rm N2W78, Baltimore, MD 21201-1595. E-mail vdilsizian{at}umm.edu

Received December 17, 2004; revision received May 22, 2005; accepted July 15, 2005.

Background— After myocardial ischemia, prolonged suppression of fatty acid metabolism may persist despite restoration of blood flow, which is called metabolic stunning. We hypothesized that a branched-chain fatty acid, ß-methyl-p-[¹²³I]-iodophenyl-pentadecanoic acid (BMIPP), might identify the presence of myocardial ischemia late after demand ischemia at rest up to 30 hours later.

Methods and Results— In 32 patients with exercise-induced ischemia on thallium SPECT, BMIPP was injected at rest within 30 hours of ischemia. SPECT images were acquired beginning 10 minutes after injection (early) and again 30 minutes after injection (delayed). Thallium and BMIPP SPECT data were read separately by 3 observers blinded to other imaging and clinical data. Agreement between BMIPP and thallium data for the presence of an abnormality on the patient level was 91% (95% CI, 75 to 98) for the early BMIPP data and 94% (95% CI, 79 to 99) for the delayed BMIPP data. Agreement between delayed BMIPP and thallium was 95% among 21 patients studied on the same day, a mean of 6.2±1.4 hours after exercise-induced ischemia, and 91% among the 11 patients studied on the next calendar day, a mean of 24.9±2.6 hours after ischemia (P=NS). The magnitude of resting BMIPP metabolic defect by semiquantitative visual analysis was correlated to the magnitude of exercise-induced thallium perfusion defect (r=0.6, P<0.001 for early BMIPP; r=0.5, P=0.005 for delayed BMIPP).

Conclusions— Metabolic imaging with BMIPP identifies patients with recent exercise-induced myocardial ischemia. These findings support the concept that BMIPP imaging can successfully demonstrate the metabolic imprint of a stress-induced ischemic episode, also known as ischemic memory.

Key Words: imaging • ischemia • metabolism • nuclear medicine • radioisotopes

This article has been cited by other articles:

				T. Asanuma, A. Uranishi, K. Masuda, F. Ishikura, S. Beppu, and S. Nakatani Assessment of Myocardial Ischemic Memory Using Persistence of Post-Systolic Thickening After Recovery From Ischemia J. Am. Coll. Cardiol. Img., November 1, 2009; 2(11): 1253 - 1261. [Abstract] [Full Text] [PDF]

				J. R. Lindner Contrast ultrasound molecular imaging of inflammation in cardiovascular disease Cardiovasc Res, November 1, 2009; 84(2): 182 - 189. [Abstract] [Full Text] [PDF]

				A. Saraste, S. G. Nekolla, and M. Schwaiger Cardiovascular molecular imaging: an overview Cardiovasc Res, September 1, 2009; 83(4): 643 - 652. [Abstract] [Full Text] [PDF]

				F. M. Bengel Clinical Cardiovascular Molecular Imaging J. Nucl. Med., June 1, 2009; 50(6): 837 - 840. [Abstract] [Full Text] [PDF]

				V. Dilsizian 18F-FDG Uptake as a Surrogate Marker for Antecedent Ischemia J. Nucl. Med., December 1, 2008; 49(12): 1909 - 1911. [Full Text] [PDF]

				K.-F. Dou, M.-F. Yang, Y.-J. Yang, D. Jain, and Z.-X. He Myocardial 18F-FDG Uptake After Exercise-Induced Myocardial Ischemia in Patients with Coronary Artery Disease J. Nucl. Med., December 1, 2008; 49(12): 1986 - 1991. [Abstract] [Full Text] [PDF]

				A. L. Baggish and C. A. Boucher Radiopharmaceutical Agents for Myocardial Perfusion Imaging Circulation, October 14, 2008; 118(16): 1668 - 1674. [Full Text] [PDF]

				S. H. Rahimtoola, V. Dilsizian, C. M. Kramer, T. H. Marwick, and J.-L. J. Vanoverschelde Chronic ischemic left ventricular dysfunction from pathophysiology to imaging and its integration into clinical practice. J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 536 - 555. [Abstract] [Full Text] [PDF]

				T. Higuchi and F. M Bengel Cardiovascular nuclear imaging: from perfusion to molecular function Heart, June 1, 2008; 94(6): 809 - 816. [Full Text] [PDF]

				M. R. Vesely and V. Dilsizian Nuclear Cardiac Stress Testing in the Era of Molecular Medicine J. Nucl. Med., March 1, 2008; 49(3): 399 - 413. [Abstract] [Full Text] [PDF]

				M. Nishimura, K. Tsukamoto, N. Hasebe, N. Tamaki, K. Kikuchi, and T. Ono Prediction of Cardiac Death in Hemodialysis Patients by Myocardial Fatty Acid Imaging J. Am. Coll. Cardiol., January 15, 2008; 51(2): 139 - 145. [Abstract] [Full Text] [PDF]

				V. Dilsizian and J. C. Fink Deleterious Effect of Altered Myocardial Fatty Acid Metabolism in Kidney Disease J. Am. Coll. Cardiol., January 15, 2008; 51(2): 146 - 148. [Full Text] [PDF]

				B. A. Kaufmann, C. Lewis, A. Xie, A. Mirza-Mohd, and J. R. Lindner Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography Eur. Heart J., August 2, 2007; 28(16): 2011 - 2017. [Abstract] [Full Text] [PDF]

				J. C. Wu, F. M. Bengel, and S. S. Gambhir Cardiovascular Molecular Imaging Radiology, August 1, 2007; 244(2): 337 - 355. [Abstract] [Full Text] [PDF]

				F. S. Villanueva, E. Lu, S. Bowry, S. Kilic, E. Tom, J. Wang, J. Gretton, J. J. Pacella, and W. R. Wagner Myocardial Ischemic Memory Imaging With Molecular Echocardiography Circulation, January 23, 2007; 115(3): 345 - 352. [Abstract] [Full Text] [PDF]

				Y. Numaguchi, T. Sone, K. Okumura, M. Ishii, Y. Morita, R. Kubota, K. Yokouchi, H. Imai, M. Harada, H. Osanai, et al. The Impact of the Capability of Circulating Progenitor Cell to Differentiate on Myocardial Salvage in Patients With Primary Acute Myocardial Infarction Circulation, July 4, 2006; 114(1_suppl): I-114 - I-119. [Abstract] [Full Text] [PDF]

				D. Pennell Myocardial Salvage: Retrospection, Resolution, and Radio Waves Circulation, April 18, 2006; 113(15): 1821 - 1823. [Full Text] [PDF]